Form 4 for HUMA Humacyte, Inc.
Accepted 2026-05-20 16:32:09 ET · period of report 2026-05-18 · accession 0001817285-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 16:32 | 2026-05-18 | HUMA | Constantino Michael T. | Dir | P - Purchase | $0.8945 | +11.0K | 44.0K | +33% | +$9,840 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | P | A | 11,000 | $0.8945 | 43,950 | D | — | — | (F1) The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.8922 to $0.8958. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |